Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 17.45
-0.25 (-1.41%)
Apr 24, 2026, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 15.01 billion as of April 24, 2026. Its market cap has decreased by -51.72% in one year.
Market Cap
15.01B
Enterprise Value
15.52B
Revenue
40.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.45
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 15.01B, a decrease of -67.70%. That is a compound annual growth rate of -10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 15.01B | -37.38% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 25.35B |
| Lumosa Therapeutics | 21.52B |
| Sunmax Biotechnology | 21.46B |
| AP Biosciences | 17.11B |
| Medigen Vaccine Biologics | 15.39B |
| EirGenix | 14.78B |
| TaiMed Biologics | 13.66B |
| Locus Cell | 12.04B |